Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 45Uterine Cervical Neoplasms 10Melanoma 10Endometrial Neoplasms 9Mouth Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Carcinoma, Intraductal, Noninfiltrating 4Vulvar Neoplasms 3Triple Negative Breast Neoplasms 3Rectal Neoplasms 3Uterine Neoplasms 2Ovarian Neoplasms 2Neoplasm Micrometastasis 2Neoplasm Metastasis 2Lymphatic Metastasis 2Leukemia, Lymphocytic, Chronic, B-Cell 2Head and Neck Neoplasms 2Eccrine Porocarcinoma 2Colorectal Neoplasms 2Colonic Neoplasms 2Breast Neoplasms, Male 2Breast Carcinoma In Situ 2Anus Neoplasms 2Waldenstrom Macroglobulinemia 1Sentinel Lymph Node Biopsy (SLNB) 1Sentinel Lymph Node 1Sarcoidosis, Pulmonary 1Sarcoidosis 1Rhabdomyosarcoma 1Recurrence 1

Interventions

Technetium Tc 99m Sulfur Colloid 1Sentinel Lymph Node Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Eyelid Sebaceous Gland Carcinoma × Sentinel Lymph Node Biopsy × Clear all
NCT00832429 2025-07-04

Lymph Node Mapping in Finding Metastatic Disease in Patients With Sebaceous Gland Cancer of the Eyelid

M.D. Anderson Cancer Center

Phase 2 Completed
20 enrolled 6 charts

Eyelid Sebaceous Gland Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡